deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02554383

Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

Sponsor: Nader Shaikh

Conditions Respiratory Tract Infections Sinusitis
Interventions Amoxicillin-clavulanate Placebo
Updated 17 times since 2017 Last updated: Jun 13, 2023 Started: Feb 29, 2016 Primary completion: Mar 31, 2022 Completion: Mar 9, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Respiratory Tract Infections and Sinusitis and is currently completed. Nader Shaikh leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Apr 2019 · 6 months · monthly snapshot~Apr 2019 – ~Dec 2019 · 8 months · monthly snapshot~Dec 2019 – ~May 2020 · 5 months · monthly snapshot~May 2020 – ~Dec 2020 · 7 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Nov 2021 · 6 months · monthly snapshot~Nov 2021 – ~Jul 2022 · 8 months · monthly snapshot~Jul 2022 – ~Nov 2022 · 4 months · monthly snapshot~Nov 2022 – ~Jul 2023 · 8 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jul 2023 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  4. Nov 2022 — Jul 2023 [monthly]

    Active Not Recruiting PHASE3

  5. Jul 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

▶ Show 12 earlier versions

  1. Nov 2021 — Jul 2022 [monthly]

    Recruiting PHASE3

  2. May 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE3

  4. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Suspended → Recruiting

  5. May 2020 — Dec 2020 [monthly]

    Suspended PHASE3

    Status: Recruiting → Suspended

  6. Dec 2019 — May 2020 [monthly]

    Recruiting PHASE3

  7. Apr 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  8. Oct 2018 — Apr 2019 [monthly]

    Recruiting PHASE3

  9. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  10. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  11. Feb 2017 — Oct 2017 [monthly]

    Recruiting PHASE3

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nader Shaikh
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations